Skip to main content

COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS

Publication ,  Conference
HERSHFIELD, MS; CHAFFEE, S; KOROJOHNSON, L; SHORT, S
Published in: CLINICAL RESEARCH
April 1, 1990

Duke Scholars

Published In

CLINICAL RESEARCH

ISSN

0009-9279

Publication Date

April 1, 1990

Volume

38

Issue

2

Start / End Page

A457 / A457

Publisher

SLACK INC
 

Citation

APA
Chicago
ICMJE
MLA
NLM
HERSHFIELD, M. S., CHAFFEE, S., KOROJOHNSON, L., & SHORT, S. (1990). COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS. In CLINICAL RESEARCH (Vol. 38, pp. A457–A457). SLACK INC.
HERSHFIELD, M. S., S. CHAFFEE, L. KOROJOHNSON, and S. SHORT. “COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS.” In CLINICAL RESEARCH, 38:A457–A457. SLACK INC, 1990.
HERSHFIELD MS, CHAFFEE S, KOROJOHNSON L, SHORT S. COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS. In: CLINICAL RESEARCH. SLACK INC; 1990. p. A457–A457.
HERSHFIELD, M. S., et al. “COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS.” CLINICAL RESEARCH, vol. 38, no. 2, SLACK INC, 1990, pp. A457–A457.
HERSHFIELD MS, CHAFFEE S, KOROJOHNSON L, SHORT S. COMBINED USE OF SITE DIRECTED MUTAGENESIS AND POLYETHYLENE-GLYCOL (PEG) MODIFICATION TO DEVELOP ENZYME THERAPY FOR METABOLIC DISORDERS. CLINICAL RESEARCH. SLACK INC; 1990. p. A457–A457.

Published In

CLINICAL RESEARCH

ISSN

0009-9279

Publication Date

April 1, 1990

Volume

38

Issue

2

Start / End Page

A457 / A457

Publisher

SLACK INC